ABL1 and breast neoplasm: We have previously demonstrated direct tumor-promoting effects of visfatin on breast tumor cells mediated via c-Abl and STAT3 [36], and indirect effects via ADSC intermediaries acting via a GDF15-pAKT pathway [33].